Ongoing Clinical Trials

InPOG-LE-16-01- The Indian Childhood Cancer Survivorship Study (C2S study): After treatment completion registry of childhood cancers – Phase 1.

Principal Investigator: Dr. Rachna Seth

View Clinical Trial

InPOG-ALL-24-03- Improving Survival in Childhood Acute Lymphoblastic Leukemia in India (ISCALL): ICiCLE Implementation Study.

Principal Investigator: Dr Venkatraman Radhakrishnan

View Clinical Trial

InPHOG-NHL-24-01- A prospective multi-center study on practice, clinical outcomes, and toxicities in children with mature B-cell non-Hodgkin lymphoma treated with Rituximab-based chemotherapy regimen in India.

Principal Investigator: Dr Nirmalya Roy Moulik

View Clinical Trial

InPOG-ALL-19-02- Registry study for relapsed childhood acute lymphoblastic leukaemia using protocol ALLR1.

Principal Investigator: Prof. Vaskar Saha

View Clinical Trial

InPHOG-HIST-24-04 – A multicenter, retrospective study on demography, presentation, treatment, and outcome of Langerhans cell histiocytosis in India.

Principal Investigator: Dr Ramya Uppuluri

View Clinical Trial

InPHOG-HL-24-04 – Immunotherapeutic strategies in children and adolescents with Hodgkin lymphoma.

Principal Investigator: Dr Amita Mahajan

View Clinical Trial

INPHOG-AML-23-02- INDIAN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA Study (I-ChAMPs)

View Clinical Trial

InPHOG-OST-23-01- Evaluation of Clinicopathological characteristics, prognostic factors, and treatment outcomes in patients with osteosarcoma in children and adults treated in India.

Principal Investigator: Dr Akshay Tiwari

View Clinical Trial

InPOG-HL-19-03- Response-Adapted Management of Childhood Classical Hodgkin Lymphoma (cHL) and Early Response Assessment by Positron Emission and Computerized Tomography (PET-CT) to allow Omission of Radiotherapy in Indian Children with Treated with a Standard of Care Intensified Chemotherapy Regimen.

Principal Investigator: Dr. Gaurav Narula

View Clinical Trial

INPHOG-SUPP-22-03- “Anti-Emetic Prophylaxis for Chemotherapy-Induced Vomiting Without Dexamethasone for Children and Adolescents Receiving Highly Emetogenic Chemotherapy: Investigator- Initiated, Open-Label, Multi-Center, Non-Inferiority, Phase III Randomized Controlled Trial.

Principal Investigator: Dr. Venkatraman Radhakrishnan

View Clinical Trial

INPHOG-GCT-22-01- Integrated Clinico-pathological and treatment outcome analysis of extra-cranial malignant germ cell tumors in children and adolescents in India.

View Clinical Trial

INPHOG-EPI-22-03- ESTABLISHING THE FIRST DEDICATED POPULATION-BASED CHILDHOOD CANCER REGISTRY (PBCCR) AND NETWORK OF HOSPITAL-BASED CHILDHOOD CANCER REGISTRIES (HBCCRs) IN INDIA

View Clinical Trial

InPOG-NB-23-02- India Cooperative Neuroblastoma Study: Non-high risk (ICONS-NHR-23)

View Clinical Trial